Lupus Nephritis: all 338 studies
Page 3 of 4. Open to participants first (131), then studies with results posted, then the rest; newest registration first within each.
- Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus NephritisTerminatedNCT05962788Phase 3
- KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus NephritisTerminatedNCT05938725Phase 1/2
- Fibroblast Activating Protein Inhibitor PET Imaging in Lupus NephritisStatus unknownNCT05845151Not applicable
- A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Lupus Nephritis (ZL-1103-013)CompletedNCT05810948Phase 2
- An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus ErythematosusCompletedNCT05798117Phase 1/2
- A Study of ANX009 in Adult Participants With Lupus NephritisCompletedNCT05780515Phase 1
- An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular DiseasesActive, not recruitingNCT05732402Phase 1/2
- The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus NephritisCompletedNCT05714670Phase 2
- SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis PatientsCompletedNCT05704088Phase 4
- The Influence of Ketogenic Diet on Lupus Nephritis Patients' ImmunityStatus unknownNCT05689580Not applicable
- Atacicept in Subjects With Active Lupus Nephritis (COMPASS)WithdrawnNCT05609812Phase 3
- The Efficacy and Safety of Telitacicept and Belimumab in Active Lupus Nephritis in the Real World: a Prospective Cohort StudyStatus unknownNCT05588830
- Autologous Adoptive T Regulatory Cell Transfer in Autoimmune Diseases.Status unknownNCT05566977Phase 1
- Efficiency of Use of Baracetinib in Treatment of Lupus NephritisStatus unknownNCT05432531Phase 3
- Value of Uric Acid as Early Predictor of Lupus NephritisStatus unknownNCT05402735
- Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal BiopsyStatus unknownNCT05358652
- A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the USCompletedNCT05337124
- Voclosporin in Adolescent and Pediatric Subjects With Lupus NephritisTerminatedNCT05288855Phase 3
- Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- VTerminatedNCT05268289Phase 2
- A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in EgyptCompletedNCT05195086
- Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus NephritisActive, not recruitingNCT05138133Phase 3
- Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus NephritisActive, not recruitingNCT05126277Phase 3
- Epidemiology of Lupus Nephritis in Nephrology Unit in Assiut University HospitalStatus unknownNCT05120882
- MFERG Study of HCQ Retinopathy in Lupus Nephritis Patients: A Randomized Controlled Clinical TrialStatus unknownNCT05111158
- Pharmacokinetically-driven Dosing of Mycophenolate Mofetil for the Treatment of Pediatric Proliferative Lupus NephritisWithdrawnNCT05101447Phase 2
- A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Immune NephritisStatus unknownNCT05085418Early Phase 1
- The Expression Profile of New Complement Components in Childhood Lupus NephritisStatus unknownNCT05082363
- A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus NephritisStatus unknownNCT04924296Phase 2
- Urine Exosomes to Identify Biomarkers for LNStatus unknownNCT04894695
- Sirolimus in Treatment of Proteinuric Flares of Lupus NephritisStatus unknownNCT04892212Phase 2/3
- A Study of Nipocalimab in Adult Participants With Active Lupus NephritisWithdrawnNCT04883619Phase 2
- Pre-emptive Treatments in Lupus Nephritis Patients With Serological ReactivationCompletedNCT04870359Not applicable
- Daratumumab to Treat Active Lupus NephritisActive, not recruitingNCT04868838Phase 2
- Prognostic Factors for Treatment Responses in Patients With Active Lupus Nephritis at Sohag University HospitalStatus unknownNCT04756492
- Epigenetics in Lupus NephritisStatus unknownNCT04648059
- Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus NephritisCompletedNCT04645589
- Zanubrutinib in Participants With Active Proliferative Lupus NephritisCompletedNCT04643470Phase 2
- Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus NephritisCompletedNCT04522505
- Comparison between2 Drugs in Lupus NephritisCompletedNCT04424602Phase 4
- BAFF Levels and Lupus Nephritis (LN)WithdrawnNCT04369495
- Urinary T Cell Biomarker for Prediction in Lupus NephritisStatus unknownNCT04320797
- Allogeneic Amniotic Mesenchymal Stem Cell Therapy for Lupus NephritisCompletedNCT04318600Phase 1
- Establishing Clinical Utility of a New Diagnostic Test for Rheumatology PatientsCompletedNCT04266860Not applicable
- TF, TFPI and Plasmin as Novel Bio-markers in Early Diagnosis of Lupus NephritisStatus unknownNCT04218890
- Efficacy of Lower Dose Prednisolone in the Induction of Remission of Lupus NephritisCompletedNCT04146220Phase 4
- Metformin In Prevention of Lupus NephritisStatus unknownNCT04145687Phase 4
- Renal Resistive Index as a Marker of Severity and Treatment Outcomes in Lupus NephritisStatus unknownNCT03958851
- Identifying New Therapeutic Targets for Lupus TreatmentCompletedNCT03921398
- Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus NephritisTerminatedNCT03920059Phase 4
- Pentoxifylline in Lupus NephritisWithdrawnNCT03859570Phase 4
- Anti-ficolin-3 Antibodies in Lupus NephritisCompletedNCT03842787
- Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus NephritisCompletedNCT03828071Not applicable
- Multicenter Registry of Pediatric Lupus Nephritis in ChinaStatus unknownNCT03791827
- Synergetic B-cell Immunomodulation in SLE - 2nd Study.CompletedNCT03747159Phase 3
- Proliferative Lupus Nephritis Treatment With Chloroquine and HydroxychloroquineStatus unknownNCT03687905
- Searching for Diagnostic/Prognostic Biomarkers in SLE With Renal Involvement by Proteomic TechniquesCompletedNCT03687138
- Detection of Anti-glomerular Basement Membrane Antibodies (Anti-GBM): a Promising Biomarker for Lupus Nephritis (LN)?CompletedNCT03664908Not applicable
- Human Umbilical Cord Mesenchymal Stem Cells Treatment for Lupus Nephritis (LN)Status unknownNCT03580291Phase 2
- Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus NephritisStatus unknownNCT03526042Not applicable
- Umbilical Cord Mesenchymal Stem Cell Transplantation for Lupus NephritisStatus unknownNCT03458156Not applicable
- Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus NephritisStatus unknownNCT03214731Phase 4
- Retrospective Analysis of Renal Prognosis in Patients With Chronic Kidney DiseaseStatus unknownNCT03201406
- Cyclophosphamide Versus Mycophenolate Mofetil in Lupus NephritisCompletedNCT03200002Phase 2
- Dynamic Imaging of Variation in Lupus NephritisCompletedNCT03180021
- Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus NephritisCompletedNCT03174587Phase 1
- SSerum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus NephritisStatus unknownNCT03164720
- Anti-ficolin-2 Autoantibodies in Lupus NephritisCompletedNCT03063281
- Iguratimod as Treatment for Refractory Lupus NephritisStatus unknownNCT03054545Not applicable
- Detection of Annexin A2 in Systemic Lupus ErythematosusCompletedNCT03031925Not applicable
- Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus NephritisCompletedNCT02949349Phase 2
- The Iguratimod Effect on Lupus Nephritis (IGeLU)Status unknownNCT02936375Phase 2
- Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus NephritisCompletedNCT02645565Phase 4
- Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus NephritisCompletedNCT02630628Phase 3
- Anti-ficolin-3 Autoantibodies in Lupus NephritisCompletedNCT02625831
- The Correlation of Periostin and Renal Pathology in Chronic Kidney Disease PatientsCompletedNCT02493101
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus NephritisCompletedNCT02457221Phase 3
- Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus NephritisCompletedNCT02453997
- The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by MononuclearStatus unknownNCT02435368
- Prediction of Outcome of Lupus NephritisStatus unknownNCT02403115
- Lupus Flares and Histological Renal Activity at the End of the Treatment (LuFla)Status unknownNCT02313974
- A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus NephritisCompletedNCT02256150Phase 3
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- ACTHAR GEL in Patients With Membranous (Class V) Lupus NephritisWithdrawnNCT01926054Phase 4
- The Effect of Calcitriol on Progress and Activity of Lupus NephritisStatus unknownNCT01863641Phase 2
- Phase Ib Study of SC Milatuzumab in SLECompletedNCT01845740Phase 1
- Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus NephritisTerminatedNCT01773616Phase 3
- Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus NephropathyTerminatedNCT01765842Phase 3
- Functional MRI in Lupus NephritisCompletedNCT01731054
- RING - Rituximab for Lupus Nephritis With Remission as a GoalStatus unknownNCT01673295Phase 3
- Efficacy and Safety of Tripterygium Wilfordii in Patients With Lupus NephritisStatus unknownNCT01646736Phase 2/3
- Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus NephritisCompletedNCT01580865Not applicable
- Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus NephritisTerminatedNCT01541670Phase 1
- Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus NephritisStatus unknownNCT01539902Phase 2
- Lupus Nephritis Biomarker Study: Baseline Characteristics of PatientsCompletedNCT01470183
- A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use SituationsCompletedNCT01410747
- Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate MofetilTerminatedNCT01369628Phase 1
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis PatientsTerminatedNCT01342016Phase 3
- Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus NephritisCompletedNCT01328834Phase 3
- A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis PatientsTerminatedNCT01316133Phase 4
- Clinical Trial Treatment in Lupus NephritisWithdrawnNCT01299922Phase 3